Magnitude of pharmacological nonadherence in hypertensive patients taking antihypertensive medication from a community pharmacy in Spain

Journal of Managed Care Pharmacy

Volumn 20, Issue 12, 2014, Pages 1217-1225

  Perseguer Torregrosa, Zeneida ^a,b   Orozco Beltrán, Domingo ^b   Gil Guillen, Vicente F ^b,c   Pita Fernandez, Salvador ^d   Carratalá Munuera, Concepción ^b   Pallares Carratalá, Vicente ^e,f   Lopez Pineda, Adriana ^b  

^a Miguel Hernandez University ^*  (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c Elda Hospital   (Spain)

^d HOSPITAL JUAN CANALEJO   (Spain)

^e Mutuas Union   (Spain)

^f UNIVERSITAT JAUME I   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; CONVENIENCE SAMPLE; FEMALE; GOLD STANDARD; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MONOTHERAPY; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PERCEPTION; PHARMACIST; PHARMACY; POLYPHARMACY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SPAIN; TREATMENT REFUSAL; PREVALENCE; STATISTICS AND NUMERICAL DATA; DISEASE CONTROL;

AGED; ANTIHYPERTENSIVE AGENTS; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREVALENCE; PROSPECTIVE STUDIES; SPAIN;

EID: 84925373799     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.12.1217     Document Type: Article

References (60)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-13.
2. Lloyd-Jones D, Adams RJ, Brown TM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46-e215.
3. Grau M, Elosua R, Cabrera de León A, et al. [Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study]. Rev Esp Cardiol. 2011;64(4):295-304. [Article in Spanish]. Available at: http://www.revespcardiol.org/en/linkresolver/factores-riesgo-cardiovascular-espanaprimera/90002079/. Accessed October 2, 2014.
4. Llisterri JL, Rodriguez-Roca GC, Escobar C, et al.; Working Group of Arterial Hypertension of the Spanish Society of Primary Care Physicians Group HTA SEMERGEN; PRESCAP 2010 investigators. Treatment and blood pressure control in Spain during 2002-2010. J Hypertens. 2012;30(12):2425-31.
5. Trevisol DJ, Moreira LB, Kerkhoff A, Fuchs SC, Fuchs FD. Health-related QoL and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2011;29(2):179-88.
6. Pittman DG, Tao Z, Chen W, Stettin GD. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am J Manag Care. 2010;16(8):568-76.
7. World Health Organization. Adherence to long-term therapies: evidence for action. 2003. Available at: http://whqlibdoc.who.int/publications/2003/9241545992.pdf. Accessed October 2, 2014.
8. Puigventós Latorre F, Llodrà Ortolà V, Vilanova Boltó M, et al. [Adherence with hypertension treatment: 10 years of publications in Spain]. Med Clin (Barc). 1997;109(18):702-06. [Article in Spanish].
9. Márquez Contreras E, Gil Guillén V, Casado Martínez JJ, et al. [Analysis of studies published on hypertension treatment non-adherence in Spain between 1984 and 2005]. Aten Primaria. 2006;38(6):325-32. [Article in Spanish]. Available at: http://zl.elsevier.es/es/revista/atencion-primaria-27/analisis-los-estudios-publicados-incumplimiento-terapeutico-tratamiento-13093369-originales-2006. Accessed October 2, 2014.
10. Steele DJ, Jackson TC, Gutmann MC. Have you been taking your pills?. The adherence-monitoring sequence in the medical interview. J Fam Pract. 1990;30(3):294-99.
11. Rand C. Issues in the measurement of adherence. In: Schron E, Ockene J, Shumaker S, eds. Handbook of Health Behavior Change. New York: Springer Publishing Co.; 1990:102-10.
12. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37(9):846-57.
13. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19(4):357-62.
14. International Pharmaceutical Federation. Declaración de las normas profesionales de FIP. El papel del farmacéutico en la estimulación de la adherencia a los tratamientos de largo plazo. Sydney, Australia. September 2003. Available at: https://www.fip.org/www/uploads/database_file.php?id=220&table_id=. Accessed October 2, 2014.
15. Badia X, Roset M, Montserrat S, Herdman M, Segura A. [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]. Med Clin (Barc). 1999;112(Suppl 1):79-85. [Article in Spanish].
16. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient nonadherence?. Hypertension. 1980;2(6):757-64.
17. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
18. Salas-Salvadó J, Rubio MA, Barbany M, Moreno B; Grupo Colaborativo de la SEEDO. [SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria]. Med Clin (Barc). 2007;128(5):184-96. [Article in Spanish].
19. Toledo E, Hu FB, Estruch R, et al. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC Med. 2013;11:207.
20. Córdoba R, Cabezas C, Camarelles F, et al. [Life style recommendations]. Aten Primaria. 2012;44(Suppl 1):16-22. [Article in Spanish].
21. Marín R, de la Sierra A, Armario P, et al. [2005 Spanish guidelines on diagnosis and treatment of arterial hypertension]. Med Clin (Barc). 2005;125(1):24-34. [Article in Spanish].
22. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21(6):1011-53.
23. Grupo de Trabajo para el Tratamiento de la Hipertensión Arterial de la Sociedad Europea, Sociedad Europea de Cardiología, Mancia G, et al. [ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol. 2007;60(9):968.e1-94. [Article in Spanish].
24. Sabater-Hernández D, de la Sierra A, Sánchez-Villegas P, et al. Magnitude of the white-coat effect in the community pharmacy setting: the MEPAFAR study. Am J Hypertens. 2011;24(8):887-92.
25. Agencia Española de Protección de Datos. Ley Orgánica 15/1999, de 13 de diciembre, de Protección de Datos de Carácter Personal (BOE núm. 298, 14-12-1999, pp. 43088-43099) [Organic Law, 15/1999, for Protection of Data of Personal Nature]. Available at: http://www.agpd.es/portalwebAGPD/english_resources/regulations/index-iden-idphp.php. Accessed October 17, 2014.
26. Torres A. Fité B. Gascón P, et al. [Effectiveness of a pharmaceutical care program in the improvement of blood pressure monitoring in poorly controlled hypertensive patients. PressFarm Study]. Hipertensión. 2010;27:13-22. [Article in Spanish].
27. Márquez Contreras E, de Rivas Otero B, Divisón Garrote JA, Sobreviela Blázquez E, Luque Otero M. [Are hypertensive patients managed in primary care well evaluated and controlled? HICAP Study]. An Med Interna. 2007;24(7):312-16. [Article in Spanish].
28. Márquez Contreras E, Coca A, de la Figuera von Wichmann M, et al. [Cardiovascular risk profile of uncontrolled hypertensive patients. The Control-Project study]. Med Clin (Barc). 2007;128(3):86-91. [Article in Spanish].
29. Galarza CR, Alfie J, Waisman GD, et al. Diastolic pressure underestimates age-related hemodynamic impairment. Hypertension. 1997;30(4): 809-16.
30. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72. Available at: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf. Accessed October 2, 2014.
31. Coca A, Bertomeu V, Dalfó A, et al. [Blood pressure self-measurement: Spanish consensus document]. Nefrologia. 2007;27(2):139-53. [Article in Spanish]. Available at: http://www.revistanefrologia.com/revistas/P1-E257/P1-E257-S136-A4570.pdf. Accessed October 2, 2014.
32. Puras A, Massó J, Artigao LM, et al. [Compliance with drug treatment and degree of control in hypertension: epidemiological study. Who meets less: the patient or the doctor?] Med Clin (Barc). 2001;116(Suppl 2):101-04. [Article in Spanish].
33. García Navarro MD, Orozco Beltrán D, Gil Guillén V, Carratalá Munuera C, Terol Moltó C, Merino Sánchez J. [Relationship between drug compliance and degree of control in patients with hypertension, diabetes or dyslipidemia]. Med Clin (Barc). 2001;116(Suppl 2):141-46. [Article in Spanish].
34. Bofill C, Valenti MJ, Palmer JL, et al. Intervención sobre uso racional del medicamento:experiencia piloto en centros de atención primaria y las farmacias de su entorno. Pharm Care Esp. 2006;8(5):209-17.
35. Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Sabater-Hernández D. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study. Res Social Adm Pharm. 2013;9(6):797-805.
36. Baena-Díez JM, Gómez-Fernández C, Vilató-García M, Vásquez-Lazo EJ, Byram AO, Vidal-Solsona M. [A prescription register incorporated into computerized medical records for patients with hypertension: a new instrument to evaluate medication adherence]. Aten Primaria. 2011;43(7):336-42. [Article in Spanish].
37. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B; Guideline Development Group. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891.
38. Sackett DL, Haynes RB, Gibson ES, et al. Randomised clinical trial of strategies for improving medication adherencein primary hypertension. Lancet. 1975;1(7918):1205-07.
39. Logan AG, Milne BJ, Achber C, Campbell WP, Haynes RB. Work-site treatment of hypertension by specially trained nurses. A controlled trial. Lancet. 1979;2(8153):1175-78.
40. Baulmann J, Düsing R, Vetter H, Mengden T. [Therapy resistant hypertension-significance of electronic compliance monitoring]. Dtsch Med Wochenschr. 2002;127(45):2379-82. [Article in German].
41. Enlund H. Measuring patient compliance in antihypertensive therapy-some methodological aspects. J Clin Hosp Pharm. 1982;7(1):43-51.
42. Lim TO, Ngah BA, Rahman RA, et al. The Mentakab hypertension study project. Part V-drug adherence in hypertensive patients. Singapore Med J. 1992;33(1):63-66.
43. Guo H, He H, Jiang J. [Study on the compliance of antihypertensive drugs in patients with hypertension]. Zhonghua Liu Xing Bing Xue Za Zhi. 2001;22(6):418-20. [Article in Chinese].
44. Mounier-Vehier C, Bernaud C, Carré A, Lequeuche B, Hotton JM, Charpentier JC. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release. Am J Hypertens. 1998;11(4 Pt 1):478-86.
45. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure and low-density lipoproteincholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563-71.
46. Corrao G, Zambon A, Parodi A, et al. Discontinuation of and changes in drug therapy for hypertension among newly treated patients: a populationbased study in Italy. J Hypertens. 2008;26(4):819-24.
47. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336(7653):1114-17.
48. Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598-605.
49. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241-53.
50. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;(2):CD004804.
51. Li WW, Kuo CT, Hwang SL, Hsu HT. Factors related to medication nonadherence for patients with hypertension in Taiwan. J Clin Nurs. 2012;21 (13-14):1816-24.
52. Li WW, Wallhagen MI, Froelicher ES. Hypertension control, predictors for medication adherence and gender differences in older Chinese immigrants. J Adv Nurs. 2008;61(3):326-35.
53. Holt EW, Muntner P, Joyce CJ, Webber L, Krousel-Wood MA. Healthrelated quality of life and antihypertensive medication adherence among older adults. Age Ageing. 2010;39(4):481-87. Available at: http://ageing.oxfordjournals.org/content/39/4/481.long. Accessed October 2, 2014.
54. Trivedi RB, Ayotte B, Edelman D, Bosworth HB. The association of emotional well-being and marital status with treatment adherence among patients with hypertension. J Behav Med. 2008;31(6):489-97.
55. Pippalla RS, Chinburapa V, Duval R, Akula RS. Interrelationships of quality of life, adherence, clinical outcomes and life satisfaction: a crosssectional study on hypertensive geriatrics. J Clin Pharm Ther. 1997;22(5-6): 357-69.
56. Sicras Mainar A, Galera Llorca J, Muñoz Ortí G, Navarro Artieda R. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension]. Med Clin (Barc). 2011;136(5):183-91. [Article in Spanish].
57. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-310.
58. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-38.
59. Krousel-Wood M, Joyce C, Holt E, et al. Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults. Hypertension. 2011;58(5):804-10. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220657/. Accessed October 2, 2014.
60. Prado JC Jr, Kupek E, Mion D Jr. Validity of four indirect methods to measure adherence in primary care hypertensives. J Hum Hypertens. 2007;21(7):579-84.